The Memorial Cancer Treatment Center provides patients opportunities to participate in clinical trials. A clinical trial is a way for patients to be a part of helping doctors and scientists test new cancer treatments. For information on the clinical trials available below or eligibility to participate, please call us at 618-236-1000.
NSABP B-51/RTOG 1304: A Randomized phase III Clinical Trial evaluation Post Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XET in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy;
NRG-BR001: A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases;
RTOG 1306: A Randomized Phase II Study of Individualized Combined Modality Therapy For Stage III Non-Small Cell Lung cancer (NSCLC).
Registry of Lumpectomy Only for Breast Conservation.
Protocol: Women 70 years of age or older with favorable breast cancers haven been shown in some studies to have a low risk of recurrence without radiation. This registry allows us to follow these women and measure their risk.